CrossRef The effectiveness and safety of immune checkpoint inhibitors in conversion or neoadjuvant therapy for hepatocellular carcinoma: a meta-analysis and systematic review Lingbo Hu, Yongfu Xu, Yingli Qiao, Aidong Wang, Caidi He, Rongrong Wang BMC Cancer .2025;[Epub] CrossRef Exploring the Potential of CSTF1 as a Prognostic Biomarker in Hepatocellular Carcinoma and Its Correlation with Immune Infiltration Maimaitiming Aimaiti, Dilimulati Maimaitituxun, Xiaokaiti Yilihaer, Talifujiang Kuerban, Junling Zhu, Mieradilijiang Ainiwaer, Zhiqiang Jia, Ainiwaerjiang Abudourousuli Journal of Hepatocellular Carcinoma .2025
Salivary glands adjust to the new signaling environment
Throughout your treatment, we'll monitor your progress with regular check-ins and fine-tune your dosage as needed
There is a reason were talking about NAD+ in terms of longevity
Pharmacotherapeutic evidence Postmortem frontal cortex analyses showed higher ETC complex I in people with BD receiving lithium than those not receiving lithium [47]